Report Overview
-
Request a Free Sample to learn more about this report
The global female fertility and pregnancy rapid test market size was USD 387 million in 2022. As per our research, the market is expected to reach USD 478.5 million by 2028, exhibiting a CAGR of 3.6% during the forecast period. The COVID-19 pandemic has been unprecedented and staggering, with female fertility and pregnancy rapid test market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand.
A female fertility and pregnancy rapid test that collects data from several organs, including the skin, bones, stomach, lungs, heart, and brain. It also includes an external transmitter. The usage of these technologies enables medical personnel to spot any abnormalities and the most likely underlying causes of ailments in people. Modern additions on THE female fertility and pregnancy rapid test include an early warning system, a progress tracker, AND A CAPACITY BUILDER. A rise in the number of middle-aged and elderly individuals globally, as well as a focus on high-quality care services, are likely to contribute to the growth of the female fertility and pregnancy rapid test market shares.
Chronic conditions like cancer, diabetes, and cardiovascular disease are important variables driving the adoption of devices. Governments from all around the world have launched programmes and provided funding to support technology advancements in the fields of Female Fertility and Pregnancy Rapid Test and accessible healthcare. The growing trend of home healthcare would likely benefit this sector. Modern features like wireless networking and connectivity with smart devices benefit these gadgets. Medical equipment manufacturers now have new options for business expansion because to the use of IoT and AI. The growing market share and revenue systems for female fertility and pregnancy rapid tests are responsible for this industry's escalating growth.
COVID-19 Impact COVID-19 to Female Fertility and Pregnancy Rapid Test Market Growth
As a result of COVID-19, the demand for rapid tests to determine female fertility and pregnancy has significantly increased, and manufacturers are now focusing more on increasing production to keep up with the growing demand for these tests as well as for multi-parameter monitoring devices, blood glucose monitoring devices, cardiac monitoring devices, and temperature monitoring devices. Additionally, it is projected that the market for fast testing for pregnancy and female infertility will make up for its losses. A number of reasons, such as an ageing population and changing lifestyles, rising demand from the healthcare sector, and an increase in the number of female fertility and pregnancy rapid tests manufacturers, are contributing to the growth of the female fertility and pregnancy rapid tests market.
Latest Trends
"Health Consciousness to Increase Market Growth"
The development in chronic conditions including diabetes, stroke, and renal disease is what is driving the demand for female fertility and pregnancy fast testing. For instance, the World Health Organization (WHO) estimates that there are 422 million diabetics globally. Asthma prevalence, chronic obstructive lung disease prevalence, and cigarette use prevalence are all rapidly increasing.
Segmentation
-
Request a Free Sample to learn more about this report
- By Type Analysis
According to type, the market can be segmented into Pregnancy Test Kits, Pregnancy Test Strips, and Other amongst which Pregnancy Test Kits is the leading segment in the market.
- By Application Analysis
Based on application, the market can be divided into retail stores, online stores, gynecology and fertility clinics, and other amongst which retail stores are the leading segment in the market.
Driving Factors
"Residential Healthcare Settings to Augment the Female Fertility and Pregnancy Rapid Test Market Growth"
The key factor anticipated to fuel market growth is the spike in demand for devices used in household settings. The rising prevalence of cardiovascular illness around the world, where patients need regular monitoring, is another factor that is expected to drive market expansion. The surge in the number of elderly people around the world is another factor driving the rapid growth in female fertility and pregnancy tests. There is a higher demand in the market due to the fact that older people typically have chronic diseases that call for routine monitoring of their health. Additionally, high-tech devices like ventilators, nebulizers, oxygen monitors, and many others are expected to boost market growth because they give patients comfort.
"Wearable and Convenient Test Type to Proliferate Female Fertility and Pregnancy Rapid Test Market Expansion"
Because more women are using wearable pregnancy tests, the market is growing. Continuous temperature, glucose, blood pressure, and pulse oximetry are a few examples of patient monitoring devices, biosensors, and smart implants. Building platforms for telehealth and better patient monitoring will be easier due to advancements and the growing potential of wireless data transmission networks driving the targeted industry. Additionally, modern wearable equipment includes IoT capabilities. Wearable biosensors monitor vital signs such the ECG, blood pressure, and blood sugar, and then send the information to a central server using mobile wireless networks.
Restraining Factors
"High Cost to Restrain the Market Growth"
These expensive female fertility and pregnancy quick tests require trained healthcare professionals to manage the equipment and maintain it operating effectively for the patient's happiness and a swift recovery. However, there aren't enough people with this level of expertise and efficiency working in the healthcare field right now. Furthermore, as equipment malfunction or poor planning commonly result in system failures, it is imperative to develop techniques for anticipating and resolving a failure. Particularly for safety-critical applications that deal with human health, such as female fertility and pregnancy quick tests, risk analysis connected to system failures should be seen as vital. It is projected that these problems will impede both the market's expanding expansion and its rapidly increasing share of the overall market.
Regional Insights
-
Request a Free Sample to learn more about this report
"North America to Remain Dominant Over the Forecast Period"
North America now dominates the market for female infertility and rapid pregnancy test, and it is anticipated that this trend will continue during the anticipated time frame. The rising prevalence of reproductive illnesses, the availability of cutting-edge technology, and the demand for wireless and portable systems meant to reduce out-of-pocket expenditures are a few variables affecting the regional expansion. GE Healthcare, Edward Lifesciences, and Natus Medical, among other significant market participants, are investing in R&D to develop more advanced patient monitoring facilities, which will support the industry's growth.
The Asia-Pacific region is predicted to have lucrative growth during the course of the projection. The two countries with the highest populations are China and India, and during the anticipated time, these numbers are anticipated to rise. This causes a rise in diabetes prevention awareness, which further boosts market growth.
Key Industry Players
"Market Players Focus on New Product Launches to Strengthen Market Position"
Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and the launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.
List of Market Players Profiled
- BioMerieux (France)
- Abbott (U.S.)
- Church & Dwight (U.S.)
- Quidel (U.S.)
- Clinical Guard (U.S.)
Report Coverage
This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
| REPORT COVERAGE | DETAILS |
|---|---|
Market Size Value In |
US$ 387 Million in 2022 |
Market Size Value By |
US$ 478.5 Million by 2028 |
Growth Rate |
CAGR of 3.6% from 2022 to 2028 |
Forecast Period |
2022-2028 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the Female Fertility and Pregnancy Rapid Test Market expected to touch by 2028?
The global Female Fertility and Pregnancy Rapid Test Market size is expected to reach USD 478.5 million by 2028.
-
What CAGR is the Female Fertility and Pregnancy Rapid Test Market expected to exhibit by 2028?
The Female Fertility and Pregnancy Rapid Test Market is expected to exhibit a CAGR of 3.6% by 2028.
-
Which are the driving factors of the Female Fertility and Pregnancy Rapid Test market?
The driving factors of the Female Fertility and Pregnancy Rapid Test market are Residential Healthcare Settings and Wearable and Convenient Test Type.
-
Which are the key players or most dominating companies functioning in the Female Fertility and Pregnancy Rapid Test market?
The dominating companies in the Female Fertility and Pregnancy Rapid Test market are BioMerieux (France), Abbott (U.S.), Church & Dwight (U.S.), Quidel (U.S.), and Clinical Guard (U.S.)
